CollaGenex (CGPI) FDA PENDING Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CollaGenex (CGPI) FDA PENDING

CGPI 0.0001000

0.0%

Jul 21 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rich H who wrote (72)	2/21/2000 9:34:00 AM
From: biowa	Read Replies (1) of 142

Rich, FWIW, it may just be that the co. doesn't really have anything that's sexy now (i.e., no genomics, no gt, no mAbs). Metastat may provide some upside sizzle, but right now I give it zero valuation and I think the co. is being very conservative since it lies outside the main focus. What the company is doing is very effectively (IMO) going about its business of selling Periostat and steadily (and rapidly) growing those sales, as well as adding to the clinical support for uses. On top of this, they're building a highly effective dental pharmaceutical sales force that will probably add additional products this year to a bag that already includes Periostat, Vioxx and Denavir. In other words, they're growing revenues. biowa

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next